Unfortunately, the best of these cancer-fighting compounds cannot be patented and developed by a pharmaceutical company, because it was published before the discovery of its incredible potential.
In 1997, John Huffman, a Clemson faculty member for 45 years who has led this research at the school for 20 years, created a compound and named it with his initials, JWH-133. He then published it in a 1998 edition of Bioorganic and Medicinal Chemistry, not realizing the possibility of a revolutionary drug coming from the compound.
Friday, February 04, 2005
The Tragedy of Publication
Sometimes the patent laws really can screw up your day. Again we see the importance of contemporaneous recognition and appreciation. From this article:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment